Designed specifically for big AI projects, Gefion - named after the Norse goddess of fertility - was funded to the tune of ...

Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and ...

Todd Engel claims Ozempic caused his blindness. Lawsuit says Novo Nordisk failed to warn of rare vision risks.

Shares in Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, ...

An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...